3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Renal Insufficiency
1
Osteosarcoma
1
Lymphoma
1
Leukemia
1
Interventions
Temozolomide
62
Cyclophosphamide
60
Radiotherapy
48
Doxorubicin
36
Filgrastim
26
Radiation
24
Irinotecan
24
fludarabine
23
Gemcitabine
23
Magnetic Resonance Spectroscopy
21
Imatinib Mesylate
19
Etoposide
18
pembrolizumab
16
Cisplatin
15
Carboplatin
15
Biopsy
15
Bevacizumab
15
Specimen Handling
14
fludarabine phosphate
12
Nivolumab
12
Leucovorin
12
Ipilimumab
12
Granulocyte Colony-Stimulating Factor
12
Chemotherapy, Adjuvant
12
pazopanib
11
Vincristine
11
Ifosfamide
11
Melphalan
10
Erlotinib Hydrochloride
10
Docetaxel
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
glucarpidase
×
Sarcoma
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts